comparemela.com

Latest Breaking News On - மலை முகடு கையகப்படுத்தல் கார்ப் - Page 8 : comparemela.com

3 Recent De-SPAC Winners: PLBY, PCT, CHPT

3 Recent De-SPAC Winners: PLBY, PCT, CHPT PLBY Group, PureCycle Technologies, and ChargePoint s public stock have (so far) been thriving Author: Apr 21, 2021 With all the negative sentiment surrounding SPACs, we highlight 3 companies that have, so far, been successful in their debuts in the public markets. While 2/3 are down since their actual De-SPAC date, it s important to remember that they are still massively up since their SPAC IPOs. Unlike CLOV, who Chamath has gone to bat for, the short sellers haven t yet come for these stocks.  While some of the luster of peak SPAC has worn off, the deals are still huge home runs if you invested at the right price point, and exhibit the strength of potential returns for innovative companies with strong future growth prospects.  

Digital diabetes company Virta Health lands $133M to reverse diabetes

Photo by Virta Health Digital diabetes management company Virta Health scored $133 million in a Series E funding round led by Tiger Global. This financing comes on the heels of Virta’s $65 million Series D in December, which propelled it into becoming a unicorn company. With the latest cash infusion, Virta says it has doubled its valuation to $2 billion. WHAT IT DOES Virta claims it can reverse Type 2 diabetes with its treatment program that combines tracking, coaching and remote monitoring capabilities with a nutrition-based ketogenic diet. Although ketogenic diets can be controversial for their carbohydrate restrictions, Vitra was able to help 84% of patients enrolled in its study achieve an estimated HbA1c of under 6.5%, or reduce theirs by 1% or more after 90 days.

SPAC Stock Ideas for Friday (and Beware the SPAC Short Sellers)

SPAC Stock Ideas for Friday (and Beware the SPAC Short Sellers) It may not feel like it, but the SPAC market may be on track to become healthier than ever. It s yield + optionality for the win. But, be careful as the field hasn t cleared yet and short sellers will make life hard for the SPACs and investors who buy into overly hyped financials and technology. Author: Yesterday s SPAC deal announcements were met with a tepid response by the market. D8 (DEH) was only up 0.9% to $10.07 on news of its deal to merge with Vicarious Surgical and  Consonance-HFW Acquisition Corp (CHFW)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.